As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Move comes amid rising regulatory pressures
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
